REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Wuhan Yzy Biopharma Co. Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Biological Product (except Diagnostic) Manufacturing
Full name: Wuhan Yzy Biopharma Co. Ltd. Profile Updated: May 20, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Wuhan Yzy Biopharma Co. Ltd. is an enterprise based in China. Its main office is in Wuhan. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on July 08, 2010. 106 (2025) employees currently work for Wuhan Yzy Biopharma Co. Ltd.. From the latest financial highlights, Wuhan Yzy Biopharma Co. Ltd. reported a net sales revenue drop of 37.99% in 2025. A negative growth of 34.66% was recorded in its total assets. The net profit margin of Wuhan Yzy Biopharma Co. Ltd. decreased by 36.2% in 2025.

Headquarters
No. 666 Gaoxin Road, East Lake High Tech, Development Zone, Wuhan, Hubei Province
Wuhan; Hubei;

Contact Details: Purchase the Wuhan Yzy Biopharma Co. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Wuhan Yzy Biopharma Co. Ltd. report to view the information.
Outstanding Shares:
Purchase the Wuhan Yzy Biopharma Co. Ltd. report to view the information.
Financial Auditors:
Purchase the Wuhan Yzy Biopharma Co. Ltd. report to view the information.
Incorporation Date:
July 08, 2010
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
45.97%
Purchase this report to view the information.
7.1%
Purchase this report to view the information.
6.84%
Purchase this report to view the information.
6.46%
Purchase this report to view the information.
6.01%
Subsidiaries
Nanjing Youbodi Biotechnology Co., Ltd. (Hong Kong SAR, China)
100%
Shijiazhuang Shiyou Biotechnology Co., Ltd. (Hong Kong SAR, China)
100%
Wuhan Youwei Biotechnology Co., Ltd. (Hong Kong SAR, China)
100%
Company Performance
Financial values in the chart are available after Wuhan Yzy Biopharma Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-37.99%▼
Total Operating Revenue
-34.19%▼
Operating Profit
17.78%▲
EBITDA
16.73%▲
Net Profit/Loss for the Period
13.18%▲
Total Assets
-34.66%▼
Total Equity
N/A
Operating Profit Margin
-29.63%▼
Net Profit Margin
-36.2%▼
Return on Equity (ROE)
N/A
Debt / Equity
N/A
Quick Ratio
-0.53%▼
Cash Ratio
-0.18%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
JD Health International Inc.
Nanjing Pharmaceutical Company Limited
 
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (上海复星医药(集团)股份有限公司)
Shenzhen Guohua Network Security Technology Co., Ltd.
 
Jiangsu Gdk Biological Technology Co., Ltd
CANbridge Pharmaceuticals Inc. (Hong Kong) (北海康成制药有限公司 (香港))
 
Zhaoke Ophthalmology Limited (Hong Kong) (兆科眼科有限公司 (香港))
Immuneonco Biopharmaceuticals (Shanghai) Inc.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo